Resourceful, humble CEO, General Manager, VC investor, board member, and finance executive with 20+ years experience commercializing novel technologies and business models.
Deep expertise in application of technology/data to solve clinical/healthcare/pharma enterprise business process problems. Consistently successful in critical situations requiring trusted leadership, disciplined execution, pragmatic financial experience, and calculated objectivity.
Expert in managing critical inflection points – VC and M&A transaction structuring, crisis turn-arounds, capital-constrained growth, and strategic partnerships. Equally at ease articulating the 'big picture' vision or performing detailed analytics, regaining the trust of irritated customers or establishing relationships with academics, discussing complex transaction terms with investors or mentoring junior employees.
Pattern of building from scratch and doing things 'first' - built Clinical Ink's industry first 'eSource' data capture platform from $0 to >$400M Bookings; led first acquisition integration at Medidata, developed commercial strategy for first-in-class product at Fast Track, created first investment valuation methodology at Lilly Ventures, built first strategic technology 'incubator' capabilities at e.Lilly, and instituted first financial control processes at Action Target.
&nsbp;
